8H0 (8H0) News
Follow 8H0 (8H0) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Samsung Biologics to buy Polypeptide Group shares for 2.7 trln won
Samsung Biologics and Samsung Peptide will buy shares in Polypeptide Group AG worth 2.7 trln won.
EQUITY | Aug 31, 2026, 07:27 AM UTC
L
Samsung acquisition announced; aims to complete by November
Samsung announced an acquisition in July, aiming to complete the deal by November.
MNA | Aug 31, 2026, 05:48 AM UTC
M
Samsung Biologics plans PolyPeptide takeover bid in September
Samsung Biologics plans to launch a takeover bid for PolyPeptide in September.
MNA | Aug 31, 2026, 05:47 AM UTC
M
Samsung Peptide plans takeover bid for Swiss PolyPeptide
Samsung Peptide plans to launch a takeover bid for Swiss PolyPeptide.
MNA | Aug 31, 2026, 05:12 AM UTC
M
Polypeptide board recommends shareholders accept Samsung offer
Polypeptide board recommends shareholders accept a Samsung offer.
EQUITY | Aug 31, 2026, 05:05 AM UTC
L
Samsung Peptide launches tender offer for Polypeptide
Samsung Peptide has launched a tender offer for Polypeptide.
EQUITY | Aug 31, 2026, 04:58 AM UTC